MétaCan
Menu
Back to cohort
Record W4308373031 · doi:10.1093/eurheartj/ehac395

Hypertension management in patients with cardiovascular comorbidities

2022· review· en· W4308373031 on OpenAlexafffund
Lucas Lauder, Felix Mahfoud, Michel Azizi, Deepak L. Bhatt, Sebastian Ewen, Kazuomi Kario, Gianfranco Parati, Patrick Rossignol, Markus P. Schlaich, Koon Teo, Raymond R. Townsend, Costas Tsioufis, Michael A. Weber, Thomas Weber, Michael Böhm

Bibliographic record

VenueEuropean Heart Journal · 2022
Typereview
Languageen
FieldMedicine
TopicBlood Pressure and Hypertension Studies
Canadian institutionsMcMaster UniversityPopulation Health Research Institute
FundersIdorsia PharmaceuticalsDaiichi Sankyo EuropeServierHLS TherapeuticsDeutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.Assistance publique-Hôpitaux de ParisDuke Clinical Research InstituteEisaiDeutsche ForschungsgemeinschaftPfizerModernaMitsubishi Tanabe Pharma CorporationMedicines CompanyRegado BiosciencesBelvoir Media GroupBoehringer Ingelheim JapanNovo NordiskMyoKardiaReCor MedicalNational Health and Medical Research CouncilAstraZenecaAmarin CorporationIronwood Pharmaceuticals, IncorporatedNational Institutes of HealthRegeneron PharmaceuticalsBoston VA Research InstituteBoston Scientific CorporationEli Lilly and CompanyCleveland ClinicBristol-Myers SquibbCSL BehringAlnylam PharmaceuticalsAmgenKowa CompanySanofiAmerican Heart Association
KeywordsMedicineCardiologyComorbidityInternal medicineIntensive care medicine

Abstract

fetched live from OpenAlex

Arterial hypertension is a leading cause of death globally. Due to ageing, the rising incidence of obesity, and socioeconomic and environmental changes, its incidence increases worldwide. Hypertension commonly coexists with Type 2 diabetes, obesity, dyslipidaemia, sedentary lifestyle, and smoking leading to risk amplification. Blood pressure lowering by lifestyle modifications and antihypertensive drugs reduce cardiovascular (CV) morbidity and mortality. Guidelines recommend dual- and triple-combination therapies using renin-angiotensin system blockers, calcium channel blockers, and/or a diuretic. Comorbidities often complicate management. New drugs such as angiotensin receptor-neprilysin inhibitors, sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, and non-steroidal mineralocorticoid receptor antagonists improve CV and renal outcomes. Catheter-based renal denervation could offer an alternative treatment option in comorbid hypertension associated with increased sympathetic nerve activity. This review summarises the latest clinical evidence for managing hypertension with CV comorbidities.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.005
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.123
GPT teacher head0.297
Teacher spread0.174 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations199
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueEuropean Heart JournalSame topicBlood Pressure and Hypertension StudiesFrench-language works237,207